biotin has been researched along with n-acetylaspartic acid in 1 studies
| Studies (biotin) | Trials (biotin) | Recent Studies (post-2010) (biotin) | Studies (n-acetylaspartic acid) | Trials (n-acetylaspartic acid) | Recent Studies (post-2010) (n-acetylaspartic acid) |
|---|---|---|---|---|---|
| 14,847 | 95 | 3,882 | 3,689 | 227 | 1,143 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Del Bigio, MR; Jones, M; Nath, A; Olafson, K; Peeling, J | 1 |
1 other study(ies) available for biotin and n-acetylaspartic acid
| Article | Year |
|---|---|
Intraventricular injection of human immunodeficiency virus type 1 (HIV-1) tat protein causes inflammation, gliosis, apoptosis, and ventricular enlargement.
Topics: Animals; Apoptosis; Aspartic Acid; Astrocytes; Basal Ganglia; Biotin; Cerebral Cortex; Cerebral Ventricles; Encephalitis, Viral; Ependyma; gamma-Aminobutyric Acid; Gene Products, tat; Gliosis; Glutamic Acid; Hippocampus; HIV-1; Humans; Injections, Intraventricular; Magnetic Resonance Spectroscopy; Male; Neutrophils; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Staining and Labeling; tat Gene Products, Human Immunodeficiency Virus | 1998 |